{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:52Z","timestamp":1760061412794},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1007\/bf02257403","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T18:22:17Z","timestamp":1132683737000},"page":"27-32","source":"Crossref","is-referenced-by-count":4,"title":["Interaction study between remoxipride and biperiden"],"prefix":"10.1007","volume":"111","author":[{"given":"W.","family":"Yisak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Farde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"von Bahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. B.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fredriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ogenstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02257403_CR1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1192\/bjp.149.6.726","volume":"149","author":"JS Bamrah","year":"1986","unstructured":"Bamrah JS, Kumar J, Krska J, Soni SD (1986) Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects. Br J Psychiatry 149:726\u2013733","journal-title":"Br J Psychiatry"},{"issue":"Suppl 358","key":"BF02257403_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.1990.tb05284.x","volume":"82","author":"C Bahr von","year":"1990","unstructured":"Bahr C von, Movin G, Yisak W-A, Jostell K-G, Widman M (1990) Clinical pharmacokinetics of remoxipride. Acta Psychiatr Scand 82 [Suppl 358]:41\u201344","journal-title":"Acta Psychiatr Scand"},{"key":"BF02257403_CR3","first-page":"217","volume":"36","author":"L Conti","year":"1984","unstructured":"Conti L, Andreani MF, Bonollo L, Martini A (1984) Iatrogenic parkinsonism: the efficacy of treatment with biperiden. Curr Ther Res 36:217\u2013227","journal-title":"Curr Ther Res"},{"key":"BF02257403_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00174501","volume":"95","author":"L Farde","year":"1988","unstructured":"Farde L, Grind M, Nilsson M-I, Ogenstad S, Sedvall G (1988) Remoxipride \u2014 a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers. Psychopharmacology 95:157\u2013161","journal-title":"Psychopharmacology"},{"key":"BF02257403_CR5","unstructured":"Fredriksson G (1988a) Determination of biperiden in human plasma by gas chromatography-mass fragmentography. Astra Method 805\u201317 AFB 10, 1988-07-07"},{"key":"BF02257403_CR6","unstructured":"Fredriksson G (1988b) Determination of biperiden in human urine by gas chromatography-mass fragmentography. Astra Method 805\u201317 AFB 11, 1988-07-07"},{"key":"BF02257403_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.1983.tb00339.x","volume":"67","author":"T Friis","year":"1983","unstructured":"Friis T, Christensen R, Gerlach J (1983) Sodium valproate and biperiden in neuroleptic-induced parkinsonism and hyperkinesia. Acta Psychiatr Scand 67:178\u2013187","journal-title":"Acta Psychiatr Scand"},{"key":"BF02257403_CR8","first-page":"389","volume":"12","author":"J Gautier","year":"1977","unstructured":"Gautier J, Jus A, Villeneuve A, Jus K, Pires P, Villeneuve R (1977) Influence of antiparkinsonian drugs on the plasma levels of neuroleptics. Biol Psychiatry 12:389\u2013399","journal-title":"Biol Psychiatry"},{"key":"BF02257403_CR9","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York"},{"key":"BF02257403_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF00615970","volume":"29","author":"R Grimaldi","year":"1986","unstructured":"Grimaldi R, Perruca E, Ruberto G, Gelmi C, Trimarchi F, Hollman M, Crema A (1986) Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects. Eur J Clin Pharmacol 29:735\u2013737","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02257403_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00433807","volume":"72","author":"U Halbreich","year":"1980","unstructured":"Halbreich U, Sachar EJ, Nathan RS, Asnis GM, Halpern FS (1980) The effect of benztropine on the prolactin response to haloperidol. Psychopharmacology 72:61\u201365","journal-title":"Psychopharmacology"},{"key":"BF02257403_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.1979.tb00900.x","volume":"7","author":"LB Hansen","year":"1979","unstructured":"Hansen LB, Elley J, Christensen TR, Larson NE, Naestoft J, Hvidberg EF (1979) Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs. Br J Clin Pharmacol 7:75\u201380","journal-title":"Br J Clin Pharmacol"},{"key":"BF02257403_CR13","volume-title":"Non parametric statistical methods","author":"M Hollander","year":"1973","unstructured":"Hollander M, Wolfe DA (1973) Non parametric statistical methods. Wiley, New York"},{"key":"BF02257403_CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF00556903","volume":"27","author":"M Hollman","year":"1984","unstructured":"Hollman M, Brode E, Greger G, M\u00fcller-Peltzer H, Wetzelberger N (1984) Biperiden effects and plasma levels in volunteers. Eur J Clin Pharmacol 27:619\u2013621","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02257403_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4684-1218-5_10","volume-title":"Central cholinergic mechanism and adaptive dysfunction","author":"DS Janowsky","year":"1985","unstructured":"Janowsky DS, Risch SC, Judd LL, Huey LY, Parker DC (1985) Basic cholinergic systems and the pathogenesis of affective disorders. In: Singh MM, Warburton DM, Lal H (eds) Central cholinergic mechanism and adaptive dysfunction. Plenum Press, New York, pp 309\u2013353"},{"key":"BF02257403_CR16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0033291700047942","volume":"13","author":"EC Johnstone","year":"1983","unstructured":"Johnstone EC, Crow TJ, Ferrier IN, Frith CD, Owens DGC, Bourne RD, Gamble SJ (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychol Med 13:513\u2013527","journal-title":"Psychol Med"},{"issue":"Suppl 358","key":"BF02257403_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1990.tb05286.x","volume":"82","author":"K-G Jostell","year":"1990","unstructured":"Jostell K-G, Lapierre YD, and the Canadian study group (1990) Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. Acta Psychiatr Scand 82 [Suppl 358]:48\u201350","journal-title":"Acta Psychiatr Scand"},{"key":"BF02257403_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000117699","volume":"5","author":"S Lal","year":"1979","unstructured":"Lal S, Mendis T, Cervantes P, Guyda H, de Rivera JL (1979) Effects of benztropine on haloperidol induced prolactin secretion. Neuropsychobiology 5:327\u2013331","journal-title":"Neuropsychobiology"},{"issue":"Suppl 358","key":"BF02257403_CR19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0447.1990.tb05297.x","volume":"82","author":"T Lewander","year":"1990","unstructured":"Lewander T, Westerbergh S-E, Morrison D (1990) Clinical profile of remoxipride- a combined analysis of a comparative double-blind multicentre trial programme. Acta Psychiatr Scand 82 [Suppl 358]:92\u201398","journal-title":"Acta Psychiatr Scand"},{"key":"BF02257403_CR20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1176\/ajp.137.7.819","volume":"137","author":"M Linnoila","year":"1980","unstructured":"Linnoila M, Viukari M, Vaisanen (1980) Effects of anticonvulsant drugs on plasma haloperidol and thioridazine levels. Am J Psychiatry 137:819\u2013821","journal-title":"Am J Psychiatry"},{"key":"BF02257403_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.1975.tb01576.x","volume":"2","author":"S Loga","year":"1975","unstructured":"Loga S, Curry S, Lader M (1975) Interactions of orphenadrine and phenobarbitone with chlorpromazine. Plasma concentrations and effects in man. Br J Clin Pharmacol 2:197\u2013208","journal-title":"Br J Clin Pharmacol"},{"key":"BF02257403_CR22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00004714-198310000-00004","volume":"3","author":"JP McEvoy","year":"1983","unstructured":"McEvoy JP (1983) The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychopharmacol 3:288\u2013302","journal-title":"J Clin Psychopharmacol"},{"key":"BF02257403_CR23","first-page":"529","volume-title":"Long term effect of neuroleptics","author":"PL Morselli","year":"1980","unstructured":"Morselli PL, Zarifian E, Cuche H, Bianchetti G, Cotterau MJ, Deniker P (1980) Haloperidol plasma levels monitoring in psychiatric patients. In: Cattabeni P et al (eds) Long term effect of neuroleptics. Raven Press, New York, pp 529\u2013536"},{"key":"BF02257403_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0306-4530(85)90040-X","volume":"10","author":"RS Nathan","year":"1985","unstructured":"Nathan RS, Perel JM, McCarthy T, Barret DB (1985) Effect of benztropine on the diurnal prolactin responses to haloperidol. Psychoneuroendocrinology 10:71\u201376","journal-title":"Psychoneuroendocrinology"},{"key":"BF02257403_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4347(00)82491-3","volume":"526","author":"L Nilsson","year":"1990","unstructured":"Nilsson L (1990) Determination of remoxipride in plasma and urine by reversed phase column liquid chromatography. J Chromatogr 526:139\u2013150","journal-title":"J Chromatogr"},{"key":"BF02257403_CR26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(84)90567-3","volume":"102","author":"SO \u00d6gren","year":"1984","unstructured":"\u00d6gren SO, Hall H, K\u00f6hler C, Magnusson O, Lindbom LO, \u00c4ngeby K, Florvall L (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic action in the rat brain. Eur J Pharmacol 102:459\u2013474","journal-title":"Eur J Pharmacol"},{"key":"BF02257403_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2265.1976.tb01953.x","volume":"5","author":"JL Rivera De","year":"1976","unstructured":"De Rivera JL, Lal S, Ettigi P, Hontela S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptic therapy on serum levels in men and women of different age groups. Clin Endocrinol 5:273\u2013282","journal-title":"Clin Endocrinol"},{"key":"BF02257403_CR28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.133.6.646","volume":"133","author":"L Rivera-Calimlim","year":"1976","unstructured":"Rivera-Calimlim L, Nasrallah H, Strauss J, Lasagna L (1976) Clinical response and plasma levels: effect of dose and drug interactions on plasma chlorpromazine levels. Am J Psychiatry 133:646\u2013652","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02257403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02257403\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02257403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:57:36Z","timestamp":1706749056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02257403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["BF02257403"],"URL":"https:\/\/doi.org\/10.1007\/bf02257403","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}